Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice.
about
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseDopamine and glucose, obesity, and reward deficiency syndromeDevelopment of a Rapid Insulin Assay by Homogenous Time-Resolved FluorescenceEffect of the antipsychotic agent amisulpride on glucose lowering and insulin secretionAltered dopamine D2 receptor function and binding in obese OLETF ratDopamine D2 receptors contribute to increased avidity for sucrose in obese rats lacking CCK-1 receptorsTransient activation of specific neurons in mice by selective expression of the capsaicin receptor.Adipocyte apoptosis in the regulation of body fat mass by leptin.Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 miceRelationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesityRegulation of prolactin in mice with altered hypothalamic melanocortin activity.Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat.Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesityInteraction between orexins and the mesolimbic system for overriding satiety.Hypothalamic control of energy and glucose metabolism.Repeated sucrose access influences dopamine D2 receptor density in the striatum.Dopamine signaling and myopia development: What are the key challenges.Bromocriptine inhibits adipogenesis and lipogenesis by agonistic action on α2-adrenergic receptor in 3T3-L1 adipocyte cells.Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats.Dopamine transporter genotype as a risk factor for obesity in African-American smokers.Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats.Influence of methylphenidate on eating in obese men.Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high fat diet.Obese OLETF rats exhibit increased operant performance for palatable sucrose solutions and differential sensitivity to D2 receptor antagonism.Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice.Phasic Stimulation of Midbrain Dopamine Neuron Activity Reduces Salt Consumption.
P2860
Q26750370-7B7E5D9E-D570-458E-9D60-8763D23EC916Q27003334-D9503E80-37D0-4506-81B7-FF74FA5F5717Q27322836-EBE8F1CA-B33D-4D73-8FB5-55876A9CCB6EQ28252428-F0152B56-2D75-4B30-95FA-EE3AC23C056BQ30491597-93D9CE68-94A2-447C-B1FE-86596ED0B621Q30493666-1017B907-E4F3-4D3C-A307-446A7746301CQ30537339-A2B64D50-2B8B-4257-BA53-98CCA853ECA3Q34434716-93382162-569C-4B6F-8E0C-558FB906723EQ34985850-06C00835-035C-4FB0-8150-E7210DF47105Q35898332-018163F0-B274-427A-BBF2-9A6A39E71D3DQ36302543-F97E00C9-6DDF-4F10-A162-150B17BEE2F9Q37002427-4CE439E0-4CEF-4598-B85E-9DA732027545Q37189415-FF3BA855-77DF-4C9D-B5D3-16C2133C59B9Q37526843-AA9FD088-9350-44A7-9F40-EA5A8A1ADF46Q37892968-889BC90A-A0A8-423A-9E1A-CCCC0821B6FEQ38363185-C7C58347-31C4-473E-A469-5C58B6AF0C62Q39365259-B8BC7E92-E37A-4D68-9B01-634927067BB1Q42827441-C8842EE5-B35D-480D-853B-E5D7F5DA669EQ43909014-7478CFF5-4E49-4864-B0E4-464A6EAF7C06Q44255056-91C739EB-86D8-44B2-90A6-BECA6667AE00Q44472072-0E6FF519-D3A3-45AE-82B7-ACEE1858126CQ44774930-8D6CA46D-67C2-49CD-B1EA-2B5B329F68F2Q46244466-30B6EC35-2445-40FA-98D1-F98CF1082647Q48385752-2398E726-33B2-46DE-8666-4D6ADACF03C7Q48732066-0FC39A8E-7DA0-411F-A793-A1826A2A76E2Q55395571-36FB91BE-B707-4B32-9B39-7A0A6F7F4ACD
P2860
Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Bromocriptine/SKF38393 treatme ...... nctions in obese (ob/ob) mice.
@en
type
label
Bromocriptine/SKF38393 treatme ...... nctions in obese (ob/ob) mice.
@en
prefLabel
Bromocriptine/SKF38393 treatme ...... nctions in obese (ob/ob) mice.
@en
P2093
P1433
P1476
Bromocriptine/SKF38393 treatme ...... nctions in obese (ob/ob) mice.
@en
P2093
Cincotta AH
Scislowski PW
P304
P356
10.1016/S0024-3205(97)00599-7
P407
P577
1997-01-01T00:00:00Z